Ki 67 expression in 35 borderline ovarian tumours: relations with clinicopathologic parameters and ploidy.
Émile Daraï(Sorbonne Université), Jean‐Yves Scoazec(Université Paris-Saclay), Francine Walker‐Combrouze(Assistance Publique – Hôpitaux de Paris), Marie-Christine Dauge-Geoffroy(Lyon 1 Université), Patrick Madélénat(Schiller International University), Gérard Feldmann(Assistance Publique – Hôpitaux de Paris), Y. Vincent(Lyon 1 Université)
European Journal of Obstetrics & Gynecology and Reproductive Biology
February 1, 1998
Cited by 13
Related Papers
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
|Cancer Discovery|2017|781
Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma
|Nature Medicine|2018|265
Are sphincter defects the cause of anal incontinence after vaginal delivery?
|Diseases of the Colon & Rectum|2000|223
<i>SDHB</i> mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma
|International Journal of Cancer|2014|207
Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake
|Journal of Hepatology|2010|174